LymphedemaV1, PubMed, Curation, bibRecord, 002C39

Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.

Identifieur interne : 002C39 ( PubMed/Curation ); précédent : 002C38; suivant : 002C40

Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.

Auteurs : Kathryn H. Schmitz [États-Unis]

Source :

Exercise and sport sciences reviews [ 1538-3008 ] ; 2010.

RBID : pubmed:20016295

Descripteurs français

KwdFr :
- Biopsie de noeud lymphatique sentinelle (effets indésirables), Complications postopératoires (), Complications postopératoires (diagnostic), Complications postopératoires (épidémiologie), Complications postopératoires (étiologie), Comportement de réduction des risques, Exercice physique, Facteurs de risque, Femelle, Humains, Lymphoedème (), Lymphoedème (diagnostic), Lymphoedème (épidémiologie), Lymphoedème (étiologie), Prévalence, Radiothérapie (effets indésirables), Survivants, Tumeurs du sein (), Tumeurs du sein (radiothérapie), Évolution de la maladie.
MESH :
- diagnostic : Complications postopératoires, Lymphoedème.
- effets indésirables : Biopsie de noeud lymphatique sentinelle, Radiothérapie.
- radiothérapie : Tumeurs du sein.
- épidémiologie : Complications postopératoires, Lymphoedème.
- étiologie : Complications postopératoires, Lymphoedème.
- Complications postopératoires, Comportement de réduction des risques, Exercice physique, Facteurs de risque, Femelle, Humains, Lymphoedème, Prévalence, Survivants, Tumeurs du sein, Évolution de la maladie.

English descriptors

KwdEn :
- Breast Neoplasms (radiotherapy), Breast Neoplasms (surgery), Disease Progression, Exercise, Female, Humans, Lymphedema (diagnosis), Lymphedema (epidemiology), Lymphedema (etiology), Lymphedema (therapy), Postoperative Complications (diagnosis), Postoperative Complications (epidemiology), Postoperative Complications (etiology), Postoperative Complications (therapy), Prevalence, Radiotherapy (adverse effects), Risk Factors, Risk Reduction Behavior, Sentinel Lymph Node Biopsy (adverse effects), Survivors.
MESH :
- adverse effects : Radiotherapy, Sentinel Lymph Node Biopsy.
- diagnosis : Lymphedema, Postoperative Complications.
- epidemiology : Lymphedema, Postoperative Complications.
- etiology : Lymphedema, Postoperative Complications.
- radiotherapy : Breast Neoplasms.
- surgery : Breast Neoplasms.
- therapy : Lymphedema, Postoperative Complications.
- Disease Progression, Exercise, Female, Humans, Prevalence, Risk Factors, Risk Reduction Behavior, Survivors.

Abstract

Lymphedema, a common and feared negative effect of breast cancer treatment, is generally described by arm swelling and dysfunction. Risk averse clinical recommendations guided survivors to avoid the use of the affected arm. This may lead to deconditioning and, ironically, the very outcome women seek to avoid. Recently published studies run counter to these guidelines.

DOI: 10.1097/JES.0b013e3181c5cd5a
PubMed: 20016295

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002C39

Links to Exploration step

pubmed:20016295

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.</title>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Pennsylvania School of Medicine, Abramson Cancer Center, Philadelphia, 19104-6021, United States. Schmitz@mail.med.upenn.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Pennsylvania School of Medicine, Abramson Cancer Center, Philadelphia, 19104-6021</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20016295</idno>
<idno type="pmid">20016295</idno>
<idno type="doi">10.1097/JES.0b013e3181c5cd5a</idno>
<idno type="wicri:Area/PubMed/Corpus">002C39</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C39</idno>
<idno type="wicri:Area/PubMed/Curation">002C39</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C39</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.</title>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H" last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="1"><nlm:affiliation>University of Pennsylvania School of Medicine, Abramson Cancer Center, Philadelphia, 19104-6021, United States. Schmitz@mail.med.upenn.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>University of Pennsylvania School of Medicine, Abramson Cancer Center, Philadelphia, 19104-6021</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Exercise and sport sciences reviews</title>
<idno type="eISSN">1538-3008</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (radiotherapy)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Disease Progression</term>
<term>Exercise</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (epidemiology)</term>
<term>Lymphedema (etiology)</term>
<term>Lymphedema (therapy)</term>
<term>Postoperative Complications (diagnosis)</term>
<term>Postoperative Complications (epidemiology)</term>
<term>Postoperative Complications (etiology)</term>
<term>Postoperative Complications (therapy)</term>
<term>Prevalence</term>
<term>Radiotherapy (adverse effects)</term>
<term>Risk Factors</term>
<term>Risk Reduction Behavior</term>
<term>Sentinel Lymph Node Biopsy (adverse effects)</term>
<term>Survivors</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle (effets indésirables)</term>
<term>Complications postopératoires ()</term>
<term>Complications postopératoires (diagnostic)</term>
<term>Complications postopératoires (épidémiologie)</term>
<term>Complications postopératoires (étiologie)</term>
<term>Comportement de réduction des risques</term>
<term>Exercice physique</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (épidémiologie)</term>
<term>Lymphoedème (étiologie)</term>
<term>Prévalence</term>
<term>Radiothérapie (effets indésirables)</term>
<term>Survivants</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (radiothérapie)</term>
<term>Évolution de la maladie</term>
</keywords>
<keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Radiotherapy</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Complications postopératoires</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Biopsie de noeud lymphatique sentinelle</term>
<term>Radiothérapie</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term>
<term>Exercise</term>
<term>Female</term>
<term>Humans</term>
<term>Prevalence</term>
<term>Risk Factors</term>
<term>Risk Reduction Behavior</term>
<term>Survivors</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Complications postopératoires</term>
<term>Comportement de réduction des risques</term>
<term>Exercice physique</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Prévalence</term>
<term>Survivants</term>
<term>Tumeurs du sein</term>
<term>Évolution de la maladie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Lymphedema, a common and feared negative effect of breast cancer treatment, is generally described by arm swelling and dysfunction. Risk averse clinical recommendations guided survivors to avoid the use of the affected arm. This may lead to deconditioning and, ironically, the very outcome women seek to avoid. Recently published studies run counter to these guidelines.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20016295</PMID>
<DateCreated><Year>2009</Year>
<Month>12</Month>
<Day>17</Day>
</DateCreated>
<DateCompleted><Year>2010</Year>
<Month>03</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>11</Month>
<Day>22</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1538-3008</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>38</Volume>
<Issue>1</Issue>
<PubDate><Year>2010</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Exercise and sport sciences reviews</Title>
<ISOAbbreviation>Exerc Sport Sci Rev</ISOAbbreviation>
</Journal>
<ArticleTitle>Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.</ArticleTitle>
<Pagination><MedlinePgn>17-24</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/JES.0b013e3181c5cd5a</ELocationID>
<Abstract><AbstractText>Lymphedema, a common and feared negative effect of breast cancer treatment, is generally described by arm swelling and dysfunction. Risk averse clinical recommendations guided survivors to avoid the use of the affected arm. This may lead to deconditioning and, ironically, the very outcome women seek to avoid. Recently published studies run counter to these guidelines.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Schmitz</LastName>
<ForeName>Kathryn H</ForeName>
<Initials>KH</Initials>
<AffiliationInfo><Affiliation>University of Pennsylvania School of Medicine, Abramson Cancer Center, Philadelphia, 19104-6021, United States. Schmitz@mail.med.upenn.edu</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>M01 RR000400</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA106851-02</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA106851</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>M01 RR000400-360531</GrantID>
<Acronym>RR</Acronym>
<Agency>NCRR NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA106851-03</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA106851-04</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant><GrantID>R01 CA106851-01</GrantID>
<Acronym>CA</Acronym>
<Agency>NCI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Exerc Sport Sci Rev</MedlineTA>
<NlmUniqueID>0375434</NlmUniqueID>
<ISSNLinking>0091-6331</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2002 Oct 15;20(20):4242-8</RefSource>
<PMID Version="1">12377968</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>CA Cancer J Clin. 2000 Sep-Oct;50(5):292-307; quiz 308-11</RefSource>
<PMID Version="1">11075239</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Scand J Caring Sci. 2003 Mar;17(1):35-42</RefSource>
<PMID Version="1">12581293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Radiat Oncol. 2003 Jul;13(3):214-25</RefSource>
<PMID Version="1">12903011</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Semin Radiat Oncol. 2003 Jul;13(3):290-301</RefSource>
<PMID Version="1">12903017</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cardiol Clin. 2003 Aug;21(3):435-48, viii</RefSource>
<PMID Version="1">14621456</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2004 Jan;187(1):69-72</RefSource>
<PMID Version="1">14706589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Surg Oncol. 2004 Jun;11(6):573-80</RefSource>
<PMID Version="1">15172932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Appl Physiol Respir Environ Exerc Physiol. 1978 Jul;45(1):75-9</RefSource>
<PMID Version="1">670036</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vasc Med. 1997 Nov;2(4):321-6</RefSource>
<PMID Version="1">9575606</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 1998 Dec 15;83(12 Suppl American):2798-802</RefSource>
<PMID Version="1">9874400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Microcirculation. 2005 Jan-Feb;12(1):141-50</RefSource>
<PMID Version="1">15804980</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2005;3(4):208-17</RefSource>
<PMID Version="1">16379589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2006 May 1;106(9):2076-83</RefSource>
<PMID Version="1">16568409</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2006 Jun 20;24(18):2765-72</RefSource>
<PMID Version="1">16702582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Surg. 2006 Nov;192(5):636-9</RefSource>
<PMID Version="1">17071198</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Appl Physiol (1985). 2007 Sep;103(3):917-25</RefSource>
<PMID Version="1">17585046</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Oct 1;25(28):4396-404</RefSource>
<PMID Version="1">17785708</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Mar 10;26(8):1269-74</RefSource>
<PMID Version="1">18323550</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2008;6(1):29-38</RefSource>
<PMID Version="1">18361768</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 May;109(1):9-26</RefSource>
<PMID Version="1">17624588</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2008 Jul;110(1):19-37</RefSource>
<PMID Version="1">17899373</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2008 Jun 15;112(12):2809-19</RefSource>
<PMID Version="1">18428212</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2008 Sep 2;52(10):799-806</RefSource>
<PMID Version="1">18755341</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Breast Cancer Res Treat. 2009 Jan;113(2):383-91</RefSource>
<PMID Version="1">18297429</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2009 Jan 20;27(3):390-7</RefSource>
<PMID Version="1">19064976</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Sci Sports Exerc. 2009 Mar;41(3):483-9</RefSource>
<PMID Version="1">19204604</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Contemp Clin Trials. 2009 May;30(3):233-45</RefSource>
<PMID Version="1">19171204</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Aug 13;361(7):664-73</RefSource>
<PMID Version="1">19675330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Feb 1;21(3):463-6</RefSource>
<PMID Version="1">12560436</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="CommentIn"><RefSource>Exerc Sport Sci Rev. 2010 Jan;38(1):2</RefSource>
<PMID Version="1">20016292</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015444" MajorTopicYN="Y">Exercise</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011878" MajorTopicYN="N">Radiotherapy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D040242" MajorTopicYN="N">Risk Reduction Behavior</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021701" MajorTopicYN="N">Sentinel Lymph Node Biopsy</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<NumberOfReferences>35</NumberOfReferences>
<OtherID Source="NLM">NIHMS161225</OtherID>
<OtherID Source="NLM">PMC2800982</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>12</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2010</Year>
<Month>3</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20016295</ArticleId>
<ArticleId IdType="doi">10.1097/JES.0b013e3181c5cd5a</ArticleId>
<ArticleId IdType="pii">00003677-201001000-00005</ArticleId>
<ArticleId IdType="pmc">PMC2800982</ArticleId>
<ArticleId IdType="mid">NIHMS161225</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C39 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002C39 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:20016295
   |texte=   Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:20016295" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.

Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki